Hilltop Holdings’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-1,244
| Closed | -$229K | – | 654 |
|
|
2025
Q4 | $229K | Sell |
1,244
-5,875
| -83% | -$1.03M | 0.01% | 798 |
|
|
2025
Q3 | $1.09M | Buy |
+7,119
| New | +$1.08M | 0.06% | 340 |
|
|
2025
Q2 | – | Sell |
-5,947
| Closed | -$874K | – | 877 |
|
|
2025
Q1 | $874K | Buy |
5,947
+469
| +9% | +$67.9K | 0.05% | 354 |
|
|
2024
Q4 | $718K | Buy |
5,478
+794
| +17% | +$111K | 0.05% | 401 |
|
|
2024
Q3 | $730K | Buy |
+4,684
| New | +$756K | 0.05% | 384 |
|
|
2020
Q4 | – | Sell |
-3,340
| Closed | -$366K | – | 490 |
|
|
2020
Q3 | $366K | Buy |
3,340
+1,051
| +46% | +$117K | 0.06% | 280 |
|
|
2020
Q2 | $243K | Buy |
2,289
+31
| +1% | +$3.2K | 0.04% | 331 |
|
|
2020
Q1 | $202K | Sell |
2,258
-1,953
| -46% | -$184K | 0.05% | 313 |
|
|
2019
Q4 | $420K | Sell |
4,211
-1,288
| -23% | -$121K | 0.08% | 238 |
|
|
2019
Q3 | $490K | Sell |
5,499
-86
| -2% | -$7.46K | 0.09% | 211 |
|
|
2019
Q2 | $460K | Sell |
5,585
-1,783
| -24% | -$140K | 0.1% | 210 |
|
|
2019
Q1 | $596K | Sell |
7,368
-1,731
| -19% | -$136K | 0.13% | 170 |
|
|
2018
Q4 | $691K | Sell |
9,099
-3,095
| -25% | -$242K | 0.17% | 128 |
|
|
2018
Q3 | $965K | Sell |
12,194
-5,469
| -31% | -$414K | 0.2% | 128 |
|
|
2018
Q2 | $1.24M | Sell |
17,663
-1,243
| -7% | -$89.4K | 0.26% | 99 |
|
|
2018
Q1 | $1.32M | Buy |
18,906
+313
| +2% | +$21.7K | 0.23% | 109 |
|
|
2017
Q4 | $1.29M | Buy |
18,593
+1,647
| +10% | +$111K | 0.29% | 98 |
|
|
2017
Q3 | $1.15M | Buy |
16,946
+3,256
| +24% | +$206K | 0.35% | 84 |
|
|
2017
Q2 | $933K | Buy |
13,690
+3,137
| +30% | +$205K | 0.27% | 115 |
|
|
2017
Q1 | $657K | Buy |
10,553
+2,940
| +39% | +$171K | 0.2% | 150 |
|
|
2016
Q4 | $416K | Buy |
7,613
+1,026
| +16% | +$58.3K | 0.13% | 209 |
|
|
2016
Q3 | $432K | Buy |
+6,587
| New | +$431K | 0.14% | 203 |
|
|
2014
Q3 | – | Sell |
-6,749
| Closed | -$501K | – | 199 |
|
|
2014
Q2 | $501K | Sell |
6,749
-6,956
| -51% | -$503K | 0.23% | 109 |
|
|
2014
Q1 | $889K | Buy |
13,705
+6,357
| +87% | +$411K | 0.44% | 68 |
|
|
2013
Q4 | $437K | Buy |
7,348
+3,073
| +72% | +$167K | 0.22% | 113 |
|
|
2013
Q3 | $222K | Buy |
+4,275
| New | +$215K | 0.13% | 181 |
|
Other funds holding AZN
IA
VCM
VAM
Hilltop Holdings's AZN Position: Q1 2026 in Review
Hilltop Holdings sold out of AstraZeneca (AZN) in Q1 2026, closing a stake of 1,244 shares — an estimated $229K sold.
Hilltop Holdings first reported a position in AZN in Q3 2013 and held it in 26 quarters. The position peaked at $1.32M in Q1 2018. 1,377 funds tracked by Wall St. Rank hold AZN as of Q1 2026.
- Hilltop Holdings reported no remaining AstraZeneca position as of Q1 2026 after selling out during the quarter.
- Hilltop Holdings sold 1,244 AstraZeneca shares in Q1 2026, an estimated $229K.
- Hilltop Holdings first reported a position in AstraZeneca in Q3 2013 and held it in 26 quarters.
- Hilltop Holdings's AstraZeneca position peaked at $1.32M in Q1 2018.
- 1,377 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2026.
Based on Hilltop Holdings's 13F filing for Q1 2026, filed 14 May 2026.